Trametinib Synergized With Abemaciclib to Inhibit Tumor Growth in Human Head and Neck Squamous Cell Carcinoma Cells
The combination of abemaciclib and trametinib potently repressed the growth of HNSCC cells and xenografts in a synergistic manner, thus being a potential therapeutic approach for HNSCC.
Authors
- Ming Jye Poi (ORCID: https://orcid.org/0000-0001-6065-8662)
- Ernest Duah (ORCID: https://orcid.org/0000-0002-5125-0830)
- Junan Li (ORCID: https://orcid.org/0000-0003-0381-9356)
Institutions
- The Ohio State University (US)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-05-27
- DOI
- https://doi.org/10.21873/anticanres.17603
- Citations
- 1
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Ohio State University